Impact of Biopsychosocial Factors on Chronic Pain in Persons with Myotonic and Facioscapulohumeral Muscular Dystrophy

Overview

Journal Am J Hosp Palliat Care

Publisher Sage Publications

Specialties Critical Care
Nursing

Date 2009 May 6

PMID 19414560

Citations 18

Authors

Jordi Miro

Katherine A Raichle

Gregory T Carter

Sarah A OBrien

Richard T Abresch

Craig M McDonald

Mark P Jensen

Affiliations

Soon will be listed here.

Abstract

To assess the role of biopsychosocial factors in patients with type 1 myotonic and facioscapulohumeral muscular dystrophy (MMD1/FSHD) with chronic pain. Associations between psychosocial factors were found to be important in other samples of persons with pain and both psychological functioning and pain interference in a sample of patients suffering from MMD/FSHD. Prospective, multiple group, survey study of 182 patients with confirmed MMD1 and FSHD. Participants completed surveys assessing pain interference and psychological functioning, as well as psychosocial, demographic, and injury-related variables. Analyses indicated that greater catastrophizing was associated with increased pain interference and poorer psychological functioning, pain attitudes were significantly related to both pain interference and psychological functioning, and coping responses were significantly related only to pain interference. In addition, greater perceived social support was associated with better psychological functioning. The results support the use of studying pain in persons with MMD/FSHD from a biopsychosocial perspective, and the importance of identifying psychosocial factors that may play a role in the adjustment to and response to pain secondary to MMD/FSHD.

Citing Articles

Coping and Beliefs as Predictors of Functioning and Psychological Adjustment in Fibromyalgia Subgroups.

Rubio Fidel L, Garcia-Palacios A, Herrero R, Molinari G, Suso-Ribera C Pain Res Manag. 2022; 2022:1066192.

PMID: 35463626 PMC: 9023200. DOI: 10.1155/2022/1066192.

Pain in adult myotonic dystrophy type 1: relation to function and gender.

Solbakken G, Loseth S, Froholdt A, Eikeland T, Naerland T, Frich J BMC Neurol. 2021; 21(1):101.

PMID: 33663406 PMC: 7931522. DOI: 10.1186/s12883-021-02124-9.

Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).

Hamel J, Johnson N, Tawil R, Martens W, Dilek N, McDermott M Neurology. 2019; 93(12):e1180-e1192.

PMID: 31409737 PMC: 6808532. DOI: 10.1212/WNL.0000000000008123.

A Review of Psychopathology Features, Personality, and Coping in Myotonic Dystrophy Type 1.

Minier L, Lignier B, Bouvet C, Gallais B, Camart N J Neuromuscul Dis. 2018; 5(3):279-294.

PMID: 30040740 PMC: 6087440. DOI: 10.3233/JND-180310.

Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).

Heatwole C, Johnson N, Bode R, Dekdebrun J, Dilek N, Hilbert J Neurology. 2015; 85(24):2136-46.

PMID: 26581301 PMC: 4691689. DOI: 10.1212/WNL.0000000000002225.

References

Giardino N, Jensen M, Turner J, Ehde D, Cardenas D . Social environment moderates the association between catastrophizing and pain among persons with a spinal cord injury. Pain. 2003; 106(1-2):19-25. DOI: 10.1016/s0304-3959(03)00226-4. View

Engel J, Schwartz L, Jensen M, Johnson D . Pain in cerebral palsy: the relation of coping strategies to adjustment. Pain. 2000; 88(3):225-230. DOI: 10.1016/S0304-3959(00)00330-4. View

Johnson E, Abresch R, Carter G, Kilmer D, FOWLER Jr W, Sigford B . Profiles of neuromuscular diseases. Myotonic dystrophy. Am J Phys Med Rehabil. 1995; 74(5 Suppl):S104-16. View

Hill A, Niven C, Knussen C . The role of coping in adjustment to phantom limb pain. Pain. 1995; 62(1):79-86. DOI: 10.1016/0304-3959(94)00253-B. View

Daut R, Cleeland C, Flanery R . Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983; 17(2):197-210. DOI: 10.1016/0304-3959(83)90143-4. View

Jensen M, Turner J, Romano J, Strom S . The Chronic Pain Coping Inventory: development and preliminary validation. Pain. 1995; 60(2):203-216. DOI: 10.1016/0304-3959(94)00118-X. View

Carter G, Han J, Abresch R, Jensen M . The importance of assessing quality of life in patients with neuromuscular disorders. Am J Hosp Palliat Care. 2007; 23(6):493-7. DOI: 10.1177/1049909106295278. View

van der Maarel S, Frants R, Padberg G . Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta. 2006; 1772(2):186-94. DOI: 10.1016/j.bbadis.2006.05.009. View

Feyma T, Carter G, Weiss M . Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma. Muscle Nerve. 2008; 38(1):916-20. DOI: 10.1002/mus.21046. View

10.

Ehde D, Jensen M, Engel J, Turner J, Hoffman A, Cardenas D . Chronic pain secondary to disability: a review. Clin J Pain. 2003; 19(1):3-17. DOI: 10.1097/00002508-200301000-00002. View

11.

Jensen M, Turner J, Romano J . Changes in beliefs, catastrophizing, and coping are associated with improvement in multidisciplinary pain treatment. J Consult Clin Psychol. 2001; 69(4):655-62. DOI: 10.1037//0022-006x.69.4.655. View

12.

Kalkman J, Schillings M, van der Werf S, Padberg G, Zwarts M, van Engelen B . Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry. 2005; 76(10):1406-9. PMC: 1739364. DOI: 10.1136/jnnp.2004.050005. View

13.

Jensen M, Abresch R, Carter G, McDonald C . Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil. 2005; 86(6):1155-63. DOI: 10.1016/j.apmr.2004.11.028. View

14.

Nielson W, Jensen M, Hill M . An activity pacing scale for the chronic pain coping inventory: development in a sample of patients with fibromyalgia syndrome. Pain. 2001; 89(2-3):111-5. DOI: 10.1016/s0304-3959(00)00351-1. View

15.

Jensen M, Turner J, Romano J, Fisher L . Comparative reliability and validity of chronic pain intensity measures. Pain. 1999; 83(2):157-62. DOI: 10.1016/s0304-3959(99)00101-3. View

16.

Buenaver L, Edwards R, Haythornthwaite J . Pain-related catastrophizing and perceived social responses: Inter-relationships in the context of chronic pain. Pain. 2006; 127(3):234-242. PMC: 1866270. DOI: 10.1016/j.pain.2006.08.018. View

17.

Tawil R, van der Maarel S . Facioscapulohumeral muscular dystrophy. Muscle Nerve. 2006; 34(1):1-15. DOI: 10.1002/mus.20522. View

18.

Kilmer D, Abresch R, McCrory M, Carter G, FOWLER Jr W, Johnson E . Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil. 1995; 74(5 Suppl):S131-9. DOI: 10.1097/00002060-199509001-00007. View

19.

Jensen M, Engel J, Schwartz L . Coping with cerebral palsy pain: a preliminary longitudinal study. Pain Med. 2006; 7(1):30-7. DOI: 10.1111/j.1526-4637.2006.00086.x. View

20.

Tyler E, Jensen M, Engel J, Schwartz L . The reliability and validity of pain interference measures in persons with cerebral palsy. Arch Phys Med Rehabil. 2002; 83(2):236-9. DOI: 10.1053/apmr.2002.27466. View